Biotech Specialty Pharma

Mirna Therapeutics, Inc.

2150 Woodward St., Suite 100
Austin, TX 78744 USA
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Tumor-suppressing miRNA therapies

Management Paul Lammers, MD, President & CEO; Ana Ward, Esq., M.S., M.B.A., Senior Vice President & General Counsel; Lynne Hohlfeld, Chief Financial Officer & Corporate Secretary

Click here for Financial Data
Keywords: miRNA, cancer, miRNA Replacement Therapy, Oncology, Infectious Disease, Immunology


Updated: Apr. 13, 2018


Mirna Therapeutics Inc. is a biopharmaceutical research and development company focused on miRNA-directed human therapies. Mirna has identified numerous tumor-suppressing miRNAs encoded in the human g......view more

Products / Services

exclusive rights for the use of a lipid-based vehicle in the field of therapeutics.......view more

Technology / Differentiation

miRNAs...view more